FrankRep
11-09-2010, 06:28 AM
http://www.thenewamerican.com/images/stories/jbs_banners/obamacarebanner-tna.jpg (http://www.jbs.org/stopobamacare)
Choose Freedom — Stop ObamaCare on Facebook (http://www.facebook.com/ChooseFreedom.StopObamaCare).
Look out, your medicine is watching you (http://www.reuters.com/article/idUSTRE6A754720101108)
Reuters
Nov 8, 2010
Novartis AG plans to seek regulatory approval within 18 months for a pioneering tablet containing an embedded microchip, bringing the concept of "smart-pill" technology a step closer.
The initial program will use one of the Swiss firm's established drugs taken by transplant patients to avoid organ rejection. But Trevor Mundel, global head of development, believes the concept can be applied to many other pills.
"We are taking forward this transplant drug with a chip and we hope within the next 18 months to have something that we will be able to submit to the regulators, at least in Europe," Mundel told the Reuters Health Summit in New York.
"I see the promise as going much beyond that," he added.
...
Longer-term, he hopes to expand the "smart pill" concept to other types of medicine and use the wealth of biometric information the Proteus chip can collect, from heart rate and temperature to body movement, to check that drugs are working properly.
Because the tiny chips are added to existing drugs, Novartis does not expect to have to conduct full-scale clinical trials to prove the new products work. Instead, it aims to do so-called bioequivalence tests to show they are the same as the original.
A bigger issue may be what checks should be put in place to protect patients' personal medical data as it is transmitted from inside their bodies by wireless and Bluetooth.
...
SOURCE:
http://www.reuters.com/article/idUSTRE6A754720101108
Choose Freedom — Stop ObamaCare on Facebook (http://www.facebook.com/ChooseFreedom.StopObamaCare).
Look out, your medicine is watching you (http://www.reuters.com/article/idUSTRE6A754720101108)
Reuters
Nov 8, 2010
Novartis AG plans to seek regulatory approval within 18 months for a pioneering tablet containing an embedded microchip, bringing the concept of "smart-pill" technology a step closer.
The initial program will use one of the Swiss firm's established drugs taken by transplant patients to avoid organ rejection. But Trevor Mundel, global head of development, believes the concept can be applied to many other pills.
"We are taking forward this transplant drug with a chip and we hope within the next 18 months to have something that we will be able to submit to the regulators, at least in Europe," Mundel told the Reuters Health Summit in New York.
"I see the promise as going much beyond that," he added.
...
Longer-term, he hopes to expand the "smart pill" concept to other types of medicine and use the wealth of biometric information the Proteus chip can collect, from heart rate and temperature to body movement, to check that drugs are working properly.
Because the tiny chips are added to existing drugs, Novartis does not expect to have to conduct full-scale clinical trials to prove the new products work. Instead, it aims to do so-called bioequivalence tests to show they are the same as the original.
A bigger issue may be what checks should be put in place to protect patients' personal medical data as it is transmitted from inside their bodies by wireless and Bluetooth.
...
SOURCE:
http://www.reuters.com/article/idUSTRE6A754720101108